DR. YOUSUF SAYEED M.D. NPI 1932155926

NPI Details

DR. Yousuf Sayeed, M.D. is an interventional pain medicine pain medicine in Naperville, IL with 36 years of experience. The provider is interventional Pain Medicine is the discipline of medicine devoted to the diagnosis and treatment of pain and related disorders principally with the application of interventional techniques in managing subacute, chronic, persistent, and intractable pain, independently or in conjunction with other modalities of treatment. DR. Yousuf Sayeed, M.D. NPI is 1932155926. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: LOYOLA UNIVERSITY OF CHICAGO, STRITCH SCHOOL OF MEDICINE
Graduation Year:1990

The provider's business location address is:

2940 ROLLINGRIDGE RD
NAPERVILLE, IL
ZIP 60564-231
Phone: (630) 967-6000

The NPI 1932155926 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection of substance into lower spine canal using imaging guidance (HCPCS:62323)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Injection of substance into lower spine canal using imaging guidance (HCPCS:62323)
• Insertion of spinal neurostimulator electrode array through skin (HCPCS:63650)
• Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes (HCPCS:99152)
• Injection of substance into middle or upper spine canal using imaging guidance (HCPCS:62321)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• Insertion of spinal neurostimulator generator or receiver (HCPCS:63685)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level (HCPCS:64484)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• Spinal fusion (HCPCS:NAN02)

The enumeration date for this NPI number is 5/25/2006 and was last updated on 9/5/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: